UnitedHealth Group (UNH) Q4 2025 earnings summary

Executive summary

• Achieved adjusted EPS of $16.35 for 2025, slightly ahead of expectations, excluding a $1.6B net non-cash charge related to restructuring, cyberattack costs, and portfolio optimization.

• 2026 outlook targets adjusted EPS greater than $17.75, at least 8.6% growth, with measured growth across all business segments.

• Strategic focus on operational discipline, technology (notably AI), margin recovery, and value-based care, with significant asset realignment and leadership changes.

• Membership contraction expected in Medicare Advantage, Medicaid, and commercial risk, offset by margin expansion and efficiency gains.

• Major restructuring in late 2025 included a $1.6B after-tax charge for cyberattack costs, divestitures, and operational resets, excluded from adjusted results.

Financial highlights

• 2025 revenues reached $447.6B, up 12% year-over-year, with domestic membership growth of over 415,000.

• 2025 operating earnings were $19.0B, including a $2.8B charge; adjusted operating earnings were $21.7B.

• 2025 cash flows from operations were $19.7B, about 1.5x net income, exceeding expectations due to timing of payments.

• 2026 revenue guidance is ~$440B, with net earnings of at least $17.10/share and adjusted net earnings >$17.75/share.

• Debt-to-capital ratio stood at 43.9% at year-end 2025, with a target of 40% for 2026.

Outlook and guidance

• 2026 adjusted EPS growth of at least 8.6%, with double-digit improvements at UnitedHealthcare and single-digit growth at Optum segments.

• Margin expansion expected, with UnitedHealthcare operating earnings margin up 40 bps and Optum segments up 20–90 bps.

• Medical care ratio expected to improve to 88.8% ±50bps, and operating cost ratio to 12.8% ±50bps.

• Two-thirds of 2026 earnings expected in the first half due to seasonality and business mix.

• UnitedHealthcare revenues projected over $335.0B, Optum over $257.5B.